shell3
3 semanas hace
November 15th is 6 Months
May 15, 2024 (the “Agreement”) with Omega Laboratories Inc of Ohio, USA (“Omega Laboratories” or “Omega”). The Agreement provides a pathway for commercialization of Cannabix’s marijuana breathalyzer technology.
They have a series of ways to gather the 11,000,000 Warrants set a side but 1st deadline of 3,000,000 is November 15th
R&D Phase
3,000,000 of the Special Warrants will convert into Special Warrant Shares upon Omega completing a Validation Packet for Cannabix Hardware under forensic testing validation requirements. Omega will have six (6) months from the date of the Agreement to complete and certify a Validation Packet of Cannabix Hardware;
It would be nice to see them receive these Warrants on the Oct Monthly Report due the 5th of Nov and the pathway to being use would be started
They get more Once the white paper is done but have 12 Months or forward to May 15th 2025 making 12 Months
2,000,000 of the Special Warrants will convert into Special Warrant Shares upon Omega successfully converting the Validation Packet data into a white paper for publishing in peer reviewed journal and the submission of a formal proposal to use Cannabix Hardware in a prominent study. Omega will have twelve (12) months from the date of the Agreement to complete this milestone; and
Chart to me says it’s ready to go or buy more if the price drops
shell3
4 meses hace
Here’s the latest and worth more than one read
Especially after 10 Year Wait but I believe it’s coming with News about FAIMS being the Tool of the Times
$BLOZF gonna $BLO
Omega Staff, Writer• 5/15/2024• Press Release
MOGADORE, Ohio, May 16, 2024 /PRNewswire/ -- Omega Laboratories, a leading drug testing laboratory renowned for its comprehensive services, proudly announces its strategic partnership with Cannabix Technologies Inc., a pioneer in cannabis breathalyzer technology. This partnership establishes Omega as the exclusive provider of laboratory services. This collaboration marks a significant milestone in the pursuit of innovative solutions for drug testing and safety assurance.
Cannabix Technologies Inc. is at the forefront of developing advanced breath analysis tools to detect THC levels accurately and non-invasively. Leveraging their expertise and cutting-edge technology, Omega Laboratories aims to revolutionize the landscape of drug testing by integrating Cannabix's THC breathalyzer into its suite of services. With credible and extensive research backing Cannabix's technology, including validation studies demonstrating its efficacy, Omega Laboratories is confident in the reliability and accuracy of the THC breathalyzer. In partnership with Cannabix, Omega will be performing a full validation study to further demonstrate the effectiveness of the breathalyzer technology in real-world testing scenarios, ensuring unparalleled accuracy and reliability for clients.
"At Cannabix Technologies, we are thrilled to partner with Omega Laboratories, a company that upholds a tradition of excellence in drug testing, backed by their extensive accreditations and certifications,", stated, Rav Mlait, CEO of Cannabix Technologies Inc. "This partnership further solidifies our commitment to providing trusted and highly accredited solutions, offering unparalleled expertise and reliability to our clients."
The integration of Cannabix's THC breathalyzer technology into Omega Laboratories' testing protocols will enable rapid and precise detection of THC levels in breath samples. This innovative approach not only streamlines the testing process but also ensures reliable results for clients across various industries, including law enforcement, workplace safety, and healthcare.
Furthermore, as part of this collaboration, all breathalyzer samples analyzed by Omega Laboratories will undergo rigorous testing using mass spectrometry (mass spec), a gold standard in analytical chemistry. This meticulous approach reinforces Omega's commitment to delivering accurate and reliable results, maintaining the highest standards of quality and integrity.
With the rise in cannabis legalization, employers face new challenges. Traditional cannabis testing methods, such as oral fluid, urine, and hair tests, can detect cannabis use for extended periods, ranging from days to months. However, utilizing the Cannabix breathalyzer to test breath for cannabis isolates THC detection to just a few hours after use.
"Our partnership with Cannabix Technologies underscores our commitment to staying at the forefront of advancements in drug testing technology," said Bill Corl, CEO of Omega Laboratories. "By incorporating their groundbreaking THC breathalyzer technology, we are poised to enhance the accuracy, efficiency, and accessibility of cannabis testing."
With this strategic partnership, Omega Laboratories and Cannabix Technologies are poised to drive innovation and set new standards in cannabis testing, ensuring safer communities and workplaces.
https://www.omegalaboratories.com/about-omega/news/Omega-Laboratories-Partners-with-Cannabix-Technologies
shell3
5 meses hace
Outstanding: 115,144,104 for July 5, 2024
Monthly 5th Report
https://webfiles.thecse.com/Cannabix_Monthly_Progress_Report_Form_7_July_5_2024.pdf?pQRBN9wc69Y7ayOMjWUFk4kAsn3rD1by
Interesting read also the Cancellation of 1,395,000 Options set @ $0.80 CAD or $0.59 $BLOZF
We seen $0.64 $BLOZF
Why the Cancellation — Issue themselves more cheaper ones and the 10% of Outstanding was change @ the Board Meeting and now they could issue up to 15% of the 115,144,104 outstanding now which would be 17,271,615.6 total Options that can be gave and it now stands with Cancellation of 1,395,000 is about 2.65M still standing to be got or leaving roughly 15M can be gave —